During the coronavirus disease-2019 (COVID-19) pandemic there were several barriers to
treatment access and medication adherence in rheumatoid arthritis (RA) patients. There is …

The aim of this work is to trace how rheumatologists all over Egypt are approaching the
COVID-19 pandemic and what changes it has brought about in the patients' care with …

Aim of the work To study the impact on the quality of life (QoL) of rheumatoid arthritis (RA)
patients following up in a university hospital in Benin during the severe acute respiratory …

Abstract Background Coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms and severity of COVID19 are …

Background: Corona virus (COVID-19) is an emerging worldwide infectious disease that
may be followed in some patients by post COVID-19 syndrome; patients who experience …

Aim of the work To assess the clinical manifestations, imaging findings and outcomes of
corona virus disease 2019 (COVID-19) in patients with rheumatic diseases. Patients and …

Coronavirus disease (COVID-19) is a highly contagious and rapidly spreading viral infection
caused by the SARS-CoV-2 virus [1]. Since December 2019, the SARS-CoV-2 infected more …

Aim of the work To investigate the serum interleukin-20 (IL-20) level in rheumatoid arthritis
(RA) patients and to elucidate its relationship with disease activity and ultrasonographic …

The study aimed to explore the experience of coronavirus disease-2019 (COVID-19)
infection and vaccine adverse events (AEs) among rheumatologists. A validated …

The Egyptian government has acquired COVID-19 vaccines from different sources; however,
the vaccination rates and vaccine acceptance among the public remained low. News media …